Congress urged to adopt clear definition of LTC pharmacies
Published by American Pharmacists Association
The Senior Care Pharmacy Coalition (SCPC) on September 6 released a new policy brief warning how differing, conflicting regulations from federal agencies with jurisdiction over long-term care (LTC) pharmacies can threaten older adults’ care during their progression across multiple settings. The policy brief says the conflicting regulations disrupt the clinical and consultative services and care coordination necessary to improve clinical outcomes, reduce errors, sustain quality improvements, reduce waste and, control costs. It emphasizes the need for and “benefit of a statutory, legislative definition of ‘long term care pharmacy’ that will compel consistency across the relevant regulatory agencies and better enable LTC pharmacies to follow geriatric and chronic care populations across settings.” Alan Rosenbloom, president and CEO of SCPC, said educating Congress and regulatory authorities about the urgent need for consistent, updated, and streamlined oversight is a major SCPC public policy priority, and that the policy brief will be followed later this year by offering for consideration a specific, new federal definition of LTC pharmacy.
Click here to see the original article on the American Pharmacists Association website.
Recent Posts
-
Senior Care Pharmacy Coalition Opposes CMS Final Rule on Minimum Staffing Standards for LTC Facilities
The Senior Care Pharmacy Coalition (SCPC), the leading national voice for the long-term care pharmacy sector, released a statement today regarding its opposition to the Centers for Medicare & Medicaid Services (CMS) final rule on minimum staffing standards for long-term care (LTC) facilities.
-
Senior Care Pharmacy Coalition Shares Comments with CMS Regarding Medicare Part D Restructuring Guidance: “Smoothing Provisions”
SCPC filed comments with CMS in response to their guidance on the implementation of the Medicare Part D restructuring portion of the Inflation Reduction Act (IRA).
-
Drug pricing efforts threaten ‘very existence’ of LTC pharmacies: reps
President Biden in his State of the Union address last week vowed to end “Big Pharma’s” grip on prescription drug pricing and cut costs for seniors and taxpayers by another $200 million.
But the president’s plans to expand his administration’s first-ever Medicare drug price negotiations could spell big trouble for the pharmacists who support seniors living in long-term care settings, advocates warned in response.
Stay in the Know
Get the latest news and updates on issues impacting the long-term pharmacy community.